North America Immunoassay Reagents and Devices Market – Industry Trends and Forecast to 2027

  • Medical Devices
  • Published Report
  • Dec 2019
  • North America
  • 350 Pages
  • No of Tables: 84
  • No of Figures: 25

North America Immunoassay Reagents and Devices Market By Product (Reagents & Kits, Analyzers), Platform (Enzyme Immunoassay, Fluorescence Immunoassays, Chemiluminescence Immunoassays, Radioimmunoassays, Others), Technique (Enzyme-Linked Immunosorbent Assays, Enzyme-Linked Immunospot, Rapid Tests, Western Blotting, Immuno-PCR, Other), Specimen Type (Blood, Urine, Saliva, Others), Application (Oncology and Endocrinology, Hematology & Blood Screening, Cardiology, Infectious Diseases, Bone & Mineral Disorders, Autoimmune Disorders, Toxicology, Neonatal Screening, Other Applications), End User (Pharmaceutical And BioTechnique Companies, Clinical Laboratories, Hospitals, Research & Academic Laboratories, Blood Banks, Others), Country (U.S., Canada and Mexico) Market Trends and Forecast to 2027.

Market Analysis and Insights: North America Immunoassay Reagents and Devices Market

Immunoassay reagents and devices market is expected to gain market growth in the forecast period of 2020 to 2027. Data Bridge Market Research analyses that the market is growing at a CAGR of 6.7% in the forecast period of 2020 to 2027 and expected to reach USD 12,960.95 million by 2027. Wide Application of Immunoassay and increasing healthcare expenditure.

Immunoassays are the tests being performed to detect specified molecules in the on-site and in laboratory. It basically depends upon the antibody's integral ability to attach to the particular structure of the molecule (antigen) present in the sample. Antibodies are produced within the body in response to presence of antigen in the body. Antibodies are found in body fluids including blood, urine saliva, tissue fluids and others and will bind to antigen whenever it is found in the body.

The increasing cases of disorders including infectious diseases, diabetes, cancer and many other have shown a significant growth in the market for immunoassay reagents and devices due to which companies are involved in different strategic decisions such as merger and acquisition, partnership, and others. For instance, in 2017, Cancer was responsible for around 153 deaths per 100,000 populations in the U.S. Cancer is second leading disease which causes dealth in the US. Furthermore, in 2015, around 23 million persons were diagnosed with diabetes in the United States. Technological advancement in immunoassay will further create new opportunities that will impact this immunoassay reagent and devices market growth in the forecast period to 2027.

This immunoassay reagents and devices market report provides details of market share, new developments, and product pipeline analysis, impact of domestic and localised market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, product approvals, strategic decisions, product launches, geographic expansions, and technological innovations in the market. To understand the analysis and the market scenario contact us for an Analyst Brief, our team will help you create a revenue impact solution to achieve your desired goal.

North America Immunoassay Reagents and Devices Market Scope and Market Size

Immunoassay reagents and devices market is segmented of the basis of product, platform, technique, specimen type, application, and end-user. The growth among segments helps you analyse niche pockets of growth and strategies to approach the market and determine your core application areas and the difference in your target markets.

  • On the basis of product, the North America immunoassay reagents and devices market is segmented into reagents & kits and analyzers. In 2020, reagents & kits segment is exceeding the market due to extreme usage in disease detection and drug development. Increased diseases require proper diagnosis for further treatment. And hence, companies are developing number of kits and reagents and providing in market for further use. Chronic diseases such as heart disease, cancer, and diabetes are the leading causes of death and disability in the United States. For instance, according to More than 859,000 Americans die of heart disease, stroke, or other cardiovascular diseases every year.

North America Immunoassay Reagents and Devices Market

  • On the basis of platform, North America immunoassay reagents and devices market is segmented into chemiluminescence immunoassays, fluorescence immunoassays, enzyme immunoassays, radioimmunoassays, and others. In 2020, enzyme immunoassay segment is dominating the market because of its advantages such as ease in performing test, accurate result and many others.
  • On the basis of technique, North America immunoassay reagents and devices market is segmented into enzyme-linked immunosorbent assays, rapid tests, enzyme-linked immunospot, western blotting, immuno-PCR, and other techniques. In 2018 Enzyme-linked immunosorbent assays segment is dominating because it is highly sensitive, simple to perform, offer accurate result for any disease detection or in any drug development. It is one of the accurate technique that provides better diagnosis in diseases.   
  • On the basis of specimen type, North America immunoassay reagents and devices market is segmented into saliva, urine, blood, and others.in 2018, Blood segment is dominating due to Blood is easy to detect and provides accurate estimation rate for a particular foreign particle.
  • On the basis of application, North America immunoassay reagents and devices market is segmented into infectious diseases, oncology and endocrinology, bone & mineral disorders, cardiology, hematology & blood screening, autoimmune disorders, toxicology, neonatal screening, and other applications. Oncology and endocrinology segment is dominating because of high incidence rate worldwide which can be detected easily with the use of immunoassays. Along with the detection, various pharma companies are involved in developing drugs for the treatment of diseases. These diseases can be developed by using immunoassays
  • On the basis of end user, North America immunoassay reagents and devices market is segmented into hospitals, clinical laboratories, pharmaceutical and biotechnology companies, blood banks, research & academic laboratories, and others. Pharmaceutical and biotechnology segment is dominating the market as immunoassays are mostly utilized by companies to conduct various assay development for drugs, vaccines and many others

Immunoassay Reagents and Devices Market Country Level Analysis

Immunoassay reagents and devices market is analysed and market size information is provided by country by product, platform, technique, specimen type, application, and end user as referenced above.

The countries covered in the immunoassay reagents and devices market report are U.S., Canada and Mexico in North America.

It has been observed that U.S. country is dominating North America immunoassay reagents and kits market as cases of diseases are higher for which detection is required. Usage of these reagents and devices are higher in hospitals and laboratories in the  U.S. Number of pharmaceutical and biotechnology industries are more in which immunoassay requirement is high for particular drug discovery. In order to fulfil increasing demand of products immunoassay manufacturers are developing and providing products in the U.S.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, disease epidemiology and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of sales channels are considered while providing forecast analysis of the country data.

Healthcare Infrastructure Growth Installed Base and New Technology Penetration

Immunoassay reagents and devices market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for immunoassay reagents and devices market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the immunoassay reagents and devices market. The data is available for historic period 2010 to 2018.

Competitive Landscape and Immunoassay Reagents and Devices Market Share Analysis

Immunoassay reagents and devices market details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies’ focus related to immunoassay reagents and devices market.

The major players covered in the report are F. Hoffmann-La Roche Ltd, Abbott, Bio-Rad Laboratories, Inc., Merck KGaA, Siemens, Randox Laboratories Ltd., Beckman Coulter, Inc (a subsidiary of Danaher), Sysmex Corporation, bioMérieux SA, Thermo Fisher Scientific, Inc, BD, Shenzhen Mindray Bio-Medical Electronics Co., Ltd., DiaSorin S.p.A., Ortho Clinical Diagnostics (a subsidiary of Carlyle Investment Management L.L.C), QIAGEN, Quidel Corporation, BioCheck, Inc., Bio-Techne, PerkinElmer Inc, Agilent Technologies, Inc, Luminex Corporation, MESO SCALE DIAGNOSTICS, LLC and others among other players domestic and North America. Immunoassay reagents and devices market share data is available for, North America, Europe, Asia-Pacific, Middle East and Africa and South America separately. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.

Many acquisitions and developments are also initiated by the companies worldwide which are also accelerating the immunoassay reagents and devices market.

Customization Available : North America Immunoassay Reagents and Devices Market

Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customised to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analysed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Factbook) or can assist you in creating presentations from the data sets available in the report.


SKU-

TABLE 1 COST OF EIA KITS BY MERCK KGAA

TABLE 2 NORTH AMERICA IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY PRODUCT,  2018-2027 (USD MILLION)

TABLE 3 NORTH AMERICA REAGENTS AND KITS IN IMMUNOASSAY REAGEMTS AND DEVICES MARKET,  BY REGION, 2018-2027 (USD MILLION)

TABLE 4 NORTH AMERICA REAGENTS & KITS IN IMMUNOASSAY REAGENTS AND DEVICES MARKET,  BY TYPE, 2018-2027 (USD MILLION)

TABLE 5 NORTH AMERICA REAGENTS & KITS IN IMMUNOASSAY REAGENTS AND DEVICES MARKET,  BY TYPE, 2018-2027 (USD MILLION)

TABLE 6 NORTH AMERICA ANALYZERS IN IMMUNOASSAY REAGEMTS AND DEVICES MARKET,  BY REGION, 2018-2027 (USD MILLION)

TABLE 7 NORTH AMERICA ANALYZERS IN IMMUNOASSAY REAGENTS AND DEVICES MARKET,  BY TYPE, 2018-2027 (USD MILLION)

TABLE 8 NORTH AMERICA ANALYZERS IN IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY DEVICE TYPE, 2018-2027 (USD MILLION)

TABLE 9 NORTH AMERICA IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY PLATFORM,  2018-2027 (USD MILLION)

TABLE 10 NORTH AMERICA ENZYME IMMUNOASSAY IN IMMUNOASSAY REAGEMTS AND DEVICES MARKET, BY REGION, 2018-2027 (USD MILLION)

TABLE 11 NORTH AMERICA FLUORESCENCE IMMUNOASSAYS IN IMMUNOASSAY REAGEMTS AND DEVICES MARKET, BY REGION, 2018-2027 (USD MILLION)

TABLE 12 NORTH AMERICA CHEMILUMINESCENCE IMMUNOASSAYS IN IMMUNOASSAY REAGEMTS AND DEVICES MARKET, BY REGION, 2018-2027 (USD MILLION)

TABLE 13 NORTH AMERICA RADIOIMMUNOASSAYS IN IMMUNOASSAY REAGEMTS AND DEVICES MARKET,  BY REGION, 2018-2027 (USD MILLION)

TABLE 14 NORTH AMERICA OTHERS IN IMMUNOASSAY REAGEMTS AND DEVICES MARKET,  BY REGION, 2018-2027 (USD MILLION)

TABLE 15 NORTH AMERICA IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY TECHNIQUE,  2018-2027 (USD MILLION)

TABLE 16 NORTH AMERICA ENZYME-LINKED IMMUNOSORBENT ASSAYS IN IMMUNOASSAY REAGEMTS AND DEVICES MARKET, BY REGION, 2018-2027 (USD MILLION)

TABLE 17 NORTH AMERICA ENZYME-LINKED IMMUNOSPOT IN IMMUNOASSAY REAGEMTS AND DEVICES MARKET, BY REGION, 2018-2027 (USD MILLION)

TABLE 18 NORTH AMERICA RAPID TESTS IN IMMUNOASSAY REAGEMTS AND DEVICES MARKET,  BY REGION, 2018-2027 (USD MILLION)

TABLE 19 NORTH AMERICA WESTERN BLOTTING IN IMMUNOASSAY REAGEMTS AND DEVICES MARKET,  BY REGION, 2018-2027 (USD MILLION)

TABLE 20 NORTH AMERICA IMMUNO-PCR IN IMMUNOASSAY REAGEMTS AND DEVICES MARKET,  BY REGION, 2018-2027 (USD MILLION)

TABLE 21 NORTH AMERICA OTHER TECHNIQUES IN IMMUNOASSAY REAGEMTS AND DEVICES MARKET,  BY REGION, 2018-2027 (USD MILLION)

TABLE 22 NORTH AMERICA IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY SPECIMEN TYPE,  2018-2027 (USD MILLION)

TABLE 23 NORTH AMERICA BLOOD IN IMMUNOASSAY REAGEMTS AND DEVICES MARKET,  BY REGION, 2018-2027 (USD MILLION)

TABLE 24 NORTH AMERICA URINE IN IMMUNOASSAY REAGEMTS AND DEVICES MARKET,  BY REGION, 2018-2027 (USD MILLION)

TABLE 25 NORTH AMERICA SALIVA IN IMMUNOASSAY REAGEMTS AND DEVICES MARKET,  BY REGION, 2018-2027 (USD MILLION)

TABLE 26 NORTH AMERICA OTHERS IN IMMUNOASSAY REAGEMTS AND DEVICES MARKET,  BY REGION, 2018-2027 (USD MILLION)

TABLE 27 NORTH AMERICA IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY APPLICATION,  2018-2027 (USD MILLION)

TABLE 28 NORTH AMERICA ONCOLOGY AND ENDOCRINOLOGY IN IMMUNOASSAY REAGEMTS AND DEVICES MARKET, BY REGION, 2018-2027 (USD MILLION)

TABLE 29 NORTH AMERICA HEMATOLOGY & BLOOD SCREENING IN IMMUNOASSAY REAGEMTS AND DEVICES MARKET, BY REGION, 2018-2027 (USD MILLION)

TABLE 30 NORTH AMERICA CARDIOLOGY IN IMMUNOASSAY REAGEMTS AND DEVICES MARKET,  BY REGION, 2018-2027 (USD MILLION)

TABLE 31 NORTH AMERICA INFECTIOUS DISEASES IN IMMUNOASSAY REAGEMTS AND DEVICES MARKET,  BY REGION, 2018-2027 (USD MILLION)

TABLE 32 NORTH AMERICA BONE & MINERAL DISORDERS IN IMMUNOASSAY REAGEMTS AND DEVICES MARKET, BY REGION, 2018-2027 (USD MILLION)

TABLE 33 NORTH AMERICA AUTOIMMUNE DISORDERS IN IMMUNOASSAY REAGEMTS AND DEVICES MARKET, BY REGION, 2018-2027 (USD MILLION)

TABLE 34 NORTH AMERICA TOXICOLOGY IN IMMUNOASSAY REAGEMTS AND DEVICES MARKET,  BY REGION, 2018-2027 (USD MILLION)

TABLE 35 NORTH AMERICA NEONATAL SCREENING IN IMMUNOASSAY REAGEMTS AND DEVICES MARKET,  BY REGION, 2018-2027 (USD MILLION)

TABLE 36 NORTH AMERICA OTHER APPLICATIONS IN IMMUNOASSAY REAGEMTS AND DEVICES MARKET,  BY REGION, 2018-2027 (USD MILLION)

TABLE 37 NORTH AMERICA IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY END USER,  2018-2027 (USD MILLION)

TABLE 38 NORTH AMERICA PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES IN IMMUNOASSAY REAGEMTS AND DEVICES MARKET, BY REGION, 2018-2027 (USD MILLION)

TABLE 39 NORTH AMERICA CLINICAL LABORATORIES IN IMMUNOASSAY REAGEMTS AND DEVICES MARKET, BY REGION, 2018-2027 (USD MILLION)

TABLE 40 NORTH AMERICA HOSPITALS IN IMMUNOASSAY REAGEMTS AND DEVICES MARKET,  BY REGION, 2018-2027 (USD MILLION)

TABLE 41 NORTH AMERICA RESEARCH & ACADEMIC LABORATORIES IN IMMUNOASSAY REAGEMTS AND DEVICES MARKET, BY REGION, 2018-2027 (USD MILLION)

TABLE 42 NORTH AMERICA BLOOD BANKS IN IMMUNOASSAY REAGEMTS AND DEVICES MARKET,  BY REGION, 2018-2027 (USD MILLION)

TABLE 43 NORTH AMERICA OTHERS IN IMMUNOASSAY REAGEMTS AND DEVICES MARKET,  BY REGION, 2018-2027 (USD MILLION)

TABLE 44 NORTH AMERICA IMMUNOASSAY REAGENTS AND DEVICES MARKET,  BY COUNTRY, 2018-2027 (USD MILLION)

TABLE 45 NORTH AMERICA IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY PRODUCT,  2018-2027 (USD MILLION)

TABLE 46 NORTH AMERICA ANALYZERS IN IMMUNOASSAY REAGENTS AND DEVICES MARKET,  BY TYPE, 2018-2027 (USD MILLION)

TABLE 47 NORTH AMERICA ANALYZERS IN IMMUNOASSAY REAGENTS AND DEVICES MARKET,  BY DEVICE TYPE, 2018-2027 (USD MILLION)

TABLE 48 NORTH AMERICA REAGENTS & KITS IN IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 49 NORTH AMERICA ELISA REAGENTS & KITS IN IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 50 NORTH AMERICA IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY PLATFORM,  2018-2027 (USD MILLION)

TABLE 51 NORTH AMERICA IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY TECHNIQUE, 2018-2027 (USD MILLION)

TABLE 52 NORTH AMERICA IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY SPECIMEN TYPE, 2018-2027 (USD MILLION)

TABLE 53 NORTH AMERICA IMMUNOASSAY REAGENTS AND DEVICES MARKET,  BY APPLICATION, 2018-2027 (USD MILLION)

TABLE 54 NORTH AMERICA IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY END USER,  2018-2027 (USD MILLION)

TABLE 55 U.S. IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY PRODUCT,  2018-2027 (USD MILLION)

TABLE 56 U.S. ANALYZERS IN IMMUNOASSAY REAGENTS AND DEVICES MARKET,  BY TYPE, 2018-2027 (USD MILLION)

TABLE 57 U.S. ANALYZERS IN IMMUNOASSAY REAGENTS AND DEVICES MARKET,  BY DEVICE TYPE, 2018-2027 (USD MILLION)

TABLE 58 U.S. REAGENTS & KITS IN IMMUNOASSAY REAGENTS AND DEVICES MARKET,  BY TYPE, 2018-2027 (USD MILLION)

TABLE 59 U.S. ELISA REAGENTS & KITS IN IMMUNOASSAY REAGENTS AND DEVICES MARKET,  BY TYPE, 2018-2027 (USD MILLION)

TABLE 60 U.S. IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY PLATFORM,  2018-2027 (USD MILLION)

TABLE 61 U.S. IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY TECHNIQUE,  2018-2027 (USD MILLION)

TABLE 62 U.S. IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY SPECIMEN TYPE,  2018-2027 (USD MILLION)

TABLE 63 U.S. IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY APPLICATION,  2018-2027 (USD MILLION)

TABLE 64 U.S. IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY END USER,  2018-2027 (USD MILLION)

TABLE 65 CANADA IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY PRODUCT,  2018-2027 (USD MILLION)

TABLE 66 CANADA ANALYZERS IN IMMUNOASSAY REAGENTS AND DEVICES MARKET,  BY TYPE, 2018-2027 (USD MILLION)

TABLE 67 CANADA ANALYZERS IN IMMUNOASSAY REAGENTS AND DEVICES MARKET,  BY DEVICE TYPE, 2018-2027 (USD MILLION)

TABLE 68 CANADA REAGENTS & KITS IN IMMUNOASSAY REAGENTS AND DEVICES MARKET,  BY TYPE, 2018-2027 (USD MILLION)

TABLE 69 CANADA ELISA REAGENTS & KITS IN IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 70 CANADA IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY PLATFORM,  2018-2027 (USD MILLION)

TABLE 71 CANADA IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY TECHNIQUE,  2018-2027 (USD MILLION)

TABLE 72 CANADA IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY SPECIMEN TYPE,  2018-2027 (USD MILLION)

TABLE 73 CANADA IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY APPLICATION,  2018-2027 (USD MILLION)

TABLE 74 CANADA IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY END USER,  2018-2027 (USD MILLION)

TABLE 75 MEXICO IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY PRODUCT,  2018-2027 (USD MILLION)

TABLE 76 MEXICO ANALYZERS IN IMMUNOASSAY REAGENTS AND DEVICES MARKET,  BY TYPE, 2018-2027 (USD MILLION)

TABLE 77 MEXICO ANALYZERS IN IMMUNOASSAY REAGENTS AND DEVICES MARKET,  BY DEVICE TYPE, 2018-2027 (USD MILLION)

TABLE 78 MEXICO REAGENTS & KITS IN IMMUNOASSAY REAGENTS AND DEVICES MARKET,  BY TYPE, 2018-2027 (USD MILLION)

TABLE 79 MEXICO ELISA REAGENTS & KITS IN IMMUNOASSAY REAGENTS AND DEVICES MARKET,  BY TYPE, 2018-2027 (USD MILLION)

TABLE 80 MEXICO IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY PLATFORM,  2018-2027 (USD MILLION)

TABLE 81 MEXICO IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY TECHNIQUE,  2018-2027 (USD MILLION)

TABLE 82 MEXICO IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY SPECIMEN TYPE,  2018-2027 (USD MILLION)

TABLE 83 MEXICO IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY APPLICATION,  2018-2027 (USD MILLION)

TABLE 84 MEXICO IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY END USER,  2018-2027 (USD MILLION)

CHOOSE LICENCE TYPE
  • 4200.00
  • 3500.00
  • 2000.00
  • 5500.00
  • 7500.00
BUY NOW ADD TO CART
Why Choose Us
REQUEST FOR SAMPLE